BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
Clinical trial NCT06123884 · RECRUITING
Trial details
- NCT number
- NCT06123884
- Sponsor
- Bio-Thera Solutions
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2026-09-01
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.